Ancora Biotech
AcquiredFounded 2021 · $60.0M raised
- Founded
- 2021
- Business Model
- B2B
- Website
- ancorabiotech.com
- Total Funding
- $60.0M
- Last Round
- $60.0M Series AJun 2022
- Rounds
- 1
About
Ancora Biotech is a privately held company supporting the clinical development of multi-specific antibodies for infectious diseases.
Summary
Ancora Biotech is a Biotech company, founded in 2021. It has raised $60.0M in total across 1 round, most recently a $60.0M Series A round in Jun 2022. Investors include Lightspeed VP, SR One and Sutter Hill.
Tech & App Stack
2 technologies & apps tracked
Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jun 2022
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Specialty pharmaceutical company
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.